“…Various authors have reported normal flow or only a localized reduction in cerebral perfusion in nondemented patients with PD, and our present results for nondemented PD patients appear consistent with those of previous reports [4,5,23,28,29] in which rCBF was reduced in the parietal or frontal cortex, or the thalamus. Although some investigators have reported that intravenous bolus administration of L-DOPA increases CBF [30], we suspect that our results were little affected by L-DOPA, dopamine agonist, and anticholinergic therapy, since many authors [28,31,32] have reported that cortical blood flow in PD is not affected by the long-term oral administration of these drugs. Perfusion deficits in PDD, DLB, and AD, comparing 3D-SSP of Z-score maps constructed using values normalized to cerebellar perfusion between PDD, DLB, and AD patients and to normal controls.…”